Atossa Genetics (ATOS) Announces Quarterly Results
Atossa Genetics (NASDAQ:ATOS) issued its quarterly earnings data on Tuesday. The company reported ($0.23) EPS for the quarter, StockRatingsNetwork reports.
Shares of Atossa Genetics (NASDAQ:ATOS) traded down 1.69% on Tuesday, hitting $1.74. The stock had a trading volume of 147,228 shares. Atossa Genetics has a 52 week low of $1.15 and a 52 week high of $7.75. The stock has a 50-day moving average of $1.6 and a 200-day moving average of $1.71. The company’s market cap is $42.5 million.
Atossa Genetics Inc is a development-stage healthcare company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can detect precursors to breast cancer, and through the research, development, and ultimate commercialization of treatments for pre-cancerous lesions.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.